Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00207740 · ClinicalTrials.gov registry record · Phase 2
A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma
A Phase 2 study, sponsored by Centocor.
- Completed
- Registry status
- Phase 2
- Development phase
- 309
- Enrollment target
NCT00207740: Completed Phase 2 study, sponsored by Centocor.
NCT00207740 is a Phase 2 study that has completed, run by Centocor. The registered enrollment target is 309 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (132% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00207740, a Phase 2 study, has completed, sponsored by Centocor.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 309 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness and safety of CNTO 148 (golimumab) in patients with severe persistent asthma.
Primary Outcome
The endpoint is change from baseline in prebronchodilator clinic-measured percent predicted Percent-Predicted Forced Expiratory Volume in 1 Second (FEV1) with Last Observation Carried Forward (LOCF) at 6 months. The baseline visit starts at the end of 2 weeks run in phase.
Interventions
- DRUG Placebo
- DRUG CNTO148
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
What the finished NCT00207740 record still lists
NCT00207740 is an interventional study that assigns participants to a tested intervention. The registered 309 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (132% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00207740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00207740 about?
NCT00207740 is a clinical study titled "A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma". The purpose of this study is to evaluate the effectiveness and safety of CNTO 148 (golimumab) in patients with severe persistent asthma.
What is the current status of trial NCT00207740?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 309 participants. The study started on 2004-08. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00207740?
The interventions under investigation include: Placebo (DRUG), CNTO148 (DRUG).
Who is sponsoring clinical trial NCT00207740?
This trial is sponsored by Centocor, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00207740's enrollment target sits among peer trials
309 163rd of 2000 higher than 1,838 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03011684 · 309 participants · Phase 3
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
- NCT06915233 · 309 participants · Phase 3
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia